Medico RemediesNSE:MEDICO -4.12%85 Pretax Margin % is 14.64% as of Mar. 2026, which is 241% above its 10-year median of 4.29. GuruFocus rates NSE:MEDICO with a GF Score™ of 85/100 and a GF Value™ of ₹76.03 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 953 Drug Manufacturers companies, Medico Remedies ranks better than 54.35% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Medico Remedies Pretax Margin % Related Terms
Medico Remedies Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Medico Remedies's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MEDICO vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Medico Remedies's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medico Remedies Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medico Remedies's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Medico Remedies's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medico Remedies (NSE:MEDICO) has a Pretax Margin % of 14.64% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Medico Remedies and its competitors. This is 241% above median its historical median of 4.29. Over the past decade, Medico Remedies' Pretax Margin % has ranged from 2.23 to 8.95. According to the industry distribution chart, Medico Remedies ranks #435 out of 953 companies in the Drug Manufacturers industry, placing it in the top 45.6%.
Is Medico Remedies' Pretax Margin % too high?
Medico Remedies' current Pretax Margin % of 14.64% is 241% above median its 10-year median of 4.29. Over the past 10 years, this metric has ranged from a low of 2.23 to a high of 8.95. The Drug Manufacturers industry median Pretax Margin % is 7.30. Medico Remedies' value of 14.64% is 100.5% above this industry median. Based on the distribution chart, Medico Remedies ranks #435 out of 953 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Medico Remedies has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medico Remedies' Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Medico Remedies ranks #435 out of 953 companies for Pretax Margin %. This puts Medico Remedies in the upper half of its industry. The industry median Pretax Margin % is 7.30. Medico Remedies' value of 14.64% is 100.5% above this benchmark. Historically, Medico Remedies' own Pretax Margin % has ranged from 2.23 to 8.95 over the past decade. While the company's 10-year median is 4.29 vs. the industry median of 7.30, Medico Remedies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medico Remedies's current Pretax Margin % of 14.64% is 100.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Medico Remedies and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medico Remedies's current Pretax Margin % is 14.64%, which is 241% above median its own 10-year median of 4.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medico Remedies stock overvalued right now?
Based on GuruFocus' analysis, Medico Remedies (NSE:MEDICO) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹76.03, compared to a current price of ₹38.61 — trading 49.2% below its estimated fair value. The current Pretax Margin % is 14.64%, which is 241% above median its 10-year median of 4.29 and 100.5% above the Drug Manufacturers industry median of 7.30. Medico Remedies' overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Medico Remedies (NSE:MEDICO), the current Pretax Margin % is 14.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medico Remedies (NSE:MEDICO) Overvalued in 2026?
Based on GuruFocus' analysis, Medico Remedies stock appears to be undervalued.
The current stock price of ₹38.61 is trading 49.2% below its estimated GF Value™ of ₹76.03.
GuruFocus considers Medico Remedies to be Significantly Undervalued.
Key valuation signals for NSE:MEDICO:
Pretax Margin %: 14.64% (241% above median its 10-year median of 4.29)
GF Value™: ₹76.03 vs. price of ₹38.61 (49.2% below fair value)
Industry Position: 100.5% above the Drug Manufacturers median (#435 of 953)
No single metric tells the full story. See the NSE:MEDICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It operates in single segment single segment of manufacturing medicines including Antihy pertensive Antidiabetics Antibictics Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets, so many drugs used for treatment of so many diseases for oral use as well as external preparations like creams & ointments which includes anti infectives ,antifungals ,antibiotics ,steroidal preparations etc. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.
85GF Score
Get the complete analysis for NSE:MEDICO
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDICO has been successfully added to your 
